BUILDING A FUTURE WITHOUT INHERITED DISEASE
OUR MISSION
We’re building a future where no child inherits preventable disease. Through safe, ethical gene correction therapies, we give parents a new kind of choice rooted in compassion, guided by science, and governed by care.
ALLEVIATE SUFFERING
BEFORE ILLNESS BEGINS
We believe that every parent deserves the chance to give their child the healthiest possible start in life. For too long, inherited genetic conditions have been treated as fate. But with innovative technology and the right ethical guardrails, we can change that.
TRANSPARENT SCIENCE
We use precision gene correction to address inherited disease at its source, the embryo, before it can affect future generations. All of our work is conducted within the United States, under rigorous regulatory oversight and guided by deep ethical responsibility.
We do not support a permanent global moratorium on germline gene correction. We believe this science can be pursued carefully, transparently, and ethically to prevent unnecessary suffering. Banning the technology isn’t the answer. Building trust is.
We are committed to radical transparency: no secrecy, no shortcuts, and no overpromises
PREVENTION IS THE MOST COMPASSIONATE FORM OF CARE
MANHATTAN PROJECT WILL PREVENT THOUSANDS OF DISEASES
Alzheimer’s Disease
Cystic Fibrosis
Sickle Cell Anemia
Huntington’s Disease
Duchenne Muscular Dystrophy (DMD)
BUILT BY PIONEERS
Manhattan Project is led by a team of scientists, entrepreneurs, and ethical innovators who believe that the future of medicine must be both courageous and responsible.
CATHY TIE
ERIONA HYSOLLI, PhD
HELP SHAPE THE FUTURE
We welcome lead scientists and bioethicists who are motivated by the same goal: to reduce suffering across the world and do it cost-effectively.
If you're interested in sponsored research, co-publishing, or joining us to build the next generation of medicine, reach out to info@manhattangenomics.com